US Diagnostic Company Levity Increases Market Cap by 1.7 Trillion Won in One Day

On May 24 in New York trading, Revvity Inc. (REVVITY INC: RVTY) shares closed at $115, up 8.87% from the previous day. Volume rose to about 1.25 million shares, above its average, and market capitalization climbed to roughly $12.8 billion (about KRW 17 trillion), a one-day increase of around $1.25 billion (KRW 1.7 trillion).

In its Q1 2026 earnings report released May 5, Revvity posted a 7% revenue increase and earnings per share of $1.06, slightly beating market expectations. The company also disclosed that it has signed a letter of intent to divest its China immunodiagnostics business—about 6% of annual revenue—by the end of 2027. (marketbeat.com)

Headquartered in Wellesley, Massachusetts, Revvity is a life sciences and diagnostics company supplying multi-omics analysis, biomarker discovery, imaging, and diagnostic instruments to the pharmaceutical and biotech industries, with a focus on cell and gene therapy. In 2023, it spun off and reorganized its former PerkinElmer division and was subsequently listed on the New York Stock Exchange under its current name and the RVTY ticker. (en.wikipedia.org)